Literature DB >> 18408589

Bronchoalveolar immunologic profile of acute human lung transplant allograft rejection.

Aric L Gregson1, Aki Hoji, Rajan Saggar, David J Ross, Bernard M Kubak, Beth D Jamieson, S Samuel Weigt, Joseph P Lynch, Abbas Ardehali, John A Belperio, Otto O Yang.   

Abstract

Bronchoalveolar lavage fluid (BALF) offers a potential means to diagnose acute rejection and could provide insight into the immune mechanisms responsible for lung allograft rejection. Transbronchial biopsies from 29 bronchoscopic procedures were assessed for rejection. Concurrent BALF lymphocyte subsets were examined by flow cytometry, including CD4 and CD8 T cells and their activation status by CD38 expression, natural killer (NK), NK-like T (NT), B, regulatory T, and invariant receptor NK-T cells. Percentages of CD4 were reduced, and CD8 and activation of CD4 T cells correlated with rejection. There were trends for increased NT, reduced NK, and increased B cell percentages with rejection, suggesting potential roles of these cells. Among regulatory cells, the percentages of regulatory T cells decreased and CD4/CD8 invariant NK-T cells increased during rejection, suggesting a proinflammatory profile. A unique BALF lymphocyte profile was associated with rejection and may provide insight into the pathogenesis of allograft rejection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18408589      PMCID: PMC2744369          DOI: 10.1097/TP.0b013e318169bd85

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  27 in total

1.  Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.

Authors:  T J Kroshus; V R Kshettry; K Savik; R John; M I Hertz; R M Bolman
Journal:  J Thorac Cardiovasc Surg       Date:  1997-08       Impact factor: 5.209

2.  Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders.

Authors:  H Veenstra; R Baumann; N M Carroll; P T Lukey; M Kidd; N Beyers; C T Bolliger; P D van Helden; G Walzl
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

3.  Cytotoxic gammadelta or alphabeta T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2.

Authors:  M Satoh; S Seki; W Hashimoto; K Ogasawara; T Kobayashi; K Kumagai; S Matsuno; K Takeda
Journal:  J Immunol       Date:  1996-11-01       Impact factor: 5.422

4.  Transient regulatory T-cells: a state attained by all activated human T-cells.

Authors:  Vinodh Pillai; Sterling B Ortega; C K Wang; Nitin J Karandikar
Journal:  Clin Immunol       Date:  2006-12-19       Impact factor: 3.969

Review 5.  Post-transplant bronchiolitis obliterans.

Authors:  A Boehler; M Estenne
Journal:  Eur Respir J       Date:  2003-12       Impact factor: 16.671

6.  Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.

Authors:  D Heng; L D Sharples; K McNeil; S Stewart; T Wreghitt; J Wallwork
Journal:  J Heart Lung Transplant       Date:  1998-12       Impact factor: 10.247

7.  Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection.

Authors:  Dirk-Jan Slebos; Dirkje S Postma; Gerard H Koëter; Wim Van Der Bij; Marike Boezen; Henk F Kauffman
Journal:  J Heart Lung Transplant       Date:  2004-05       Impact factor: 10.247

8.  CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma.

Authors:  Omid Akbari; John L Faul; Elisabeth G Hoyte; Gerald J Berry; Jan Wahlström; Mitchell Kronenberg; Rosemarie H DeKruyff; Dale T Umetsu
Journal:  N Engl J Med       Date:  2006-03-16       Impact factor: 91.245

9.  Bronchoalveolar lavage and transbronchial lung biopsy during acute rejection and infection in heart-lung transplant patients. Studies of cell counts, lymphocyte phenotypes, and expression of HLA-DR and interleukin-2 receptor.

Authors:  C Clelland; T Higenbottam; S Stewart; B Otulana; T Wreghitt; J Gray; J Scott; J Wallwork
Journal:  Am Rev Respir Dis       Date:  1993-06

10.  Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.

Authors:  Sarah E Allan; Sarah Q Crome; Natasha K Crellin; Laura Passerini; Theodore S Steiner; Rosa Bacchetta; Maria G Roncarolo; Megan K Levings
Journal:  Int Immunol       Date:  2007-02-27       Impact factor: 4.823

View more
  23 in total

1.  Hydrodynamic stretching of single cells for large population mechanical phenotyping.

Authors:  Daniel R Gossett; Henry T K Tse; Serena A Lee; Yong Ying; Anne G Lindgren; Otto O Yang; Jianyu Rao; Amander T Clark; Dino Di Carlo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

2.  Altered Exosomal RNA Profiles in Bronchoalveolar Lavage from Lung Transplants with Acute Rejection.

Authors:  Aric L Gregson; Aki Hoji; Patil Injean; Steven T Poynter; Claudia Briones; Vyacheslav Palchevskiy; S Sam Weigt; Michael Y Shino; Ariss Derhovanessian; David Sayah; Rajan Saggar; David Ross; Abbas Ardehali; Joseph P Lynch; John A Belperio
Journal:  Am J Respir Crit Care Med       Date:  2015-12-15       Impact factor: 21.405

Review 3.  Regulatory T cells in lung transplantation--an emerging concept.

Authors:  David C Neujahr; Christian P Larsen
Journal:  Semin Immunopathol       Date:  2011-03-20       Impact factor: 9.623

Review 4.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

Review 5.  Lung transplantation: infection, inflammation, and the microbiome.

Authors:  Takeshi Nakajima; Vyachesav Palchevsky; David L Perkins; John A Belperio; Patricia W Finn
Journal:  Semin Immunopathol       Date:  2011-01-27       Impact factor: 9.623

6.  Surgical correction of gastroesophageal reflux in lung transplant patients is associated with decreased effector CD8 cells in lung lavages: a case series.

Authors:  David C Neujahr; Aminu Mohammed; Onome Ulukpo; Seth D Force; Allan M Ramirez; Andres Pelaez; E Clinton Lawrence; Christian P Larsen; Allan D Kirk
Journal:  Chest       Date:  2010-06-03       Impact factor: 9.410

7.  Detection of lung transplant rejection in a rat model using hyperpolarized [1-13 C] pyruvate-based metabolic imaging.

Authors:  Sarmad Siddiqui; Andreas Habertheuer; Yi Xin; Mehrdad Pourfathi; Jian-Qin Tao; Hooman Hamedani; Stephen Kadlecek; Ian Duncan; Prashanth Vallabhajosyula; Ali Naji; Shampa Chatterjee; Rahim Rizi
Journal:  NMR Biomed       Date:  2019-05-21       Impact factor: 4.044

8.  Innate immune activation potentiates alloimmune lung disease independent of chemokine (C-X-C motif) receptor 3.

Authors:  Tereza Martinu; Christine V Kinnier; Kymberly M Gowdy; Francine L Kelly; Laurie D Snyder; Dianhua Jiang; W Michael Foster; Stavros Garantziotis; John A Belperio; Paul W Noble; Scott M Palmer
Journal:  J Heart Lung Transplant       Date:  2011-03-27       Impact factor: 10.247

9.  Protection against bronchiolitis obliterans syndrome is associated with allograft CCR7+ CD45RA- T regulatory cells.

Authors:  Aric L Gregson; Aki Hoji; Vyacheslav Palchevskiy; Scott Hu; S Samuel Weigt; Eileen Liao; Ariss Derhovanessian; Rajeev Saggar; Sophie Song; Robert Elashoff; Otto O Yang; John A Belperio
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

Review 10.  Acute rejection and humoral sensitization in lung transplant recipients.

Authors:  Tereza Martinu; Dong-Feng Chen; Scott M Palmer
Journal:  Proc Am Thorac Soc       Date:  2009-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.